The Recall Desk
Agency classClass IOur severity:CriticalFDA (Drugs)·D-0640-2017·Announced 2017-04-12

SCA Pharmaceuticals Recalls Vancomycin IV Bags Due to Particulate Matter

SCA Pharmaceuticals is recalling specific lots of Vancomycin HCl IV bags due to the presence of particulate matter, following a related Hospira recall.

The agency’s classification

FDA (Drugs): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 5/5 (Critical).

Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The source metadata explicitly identifies the agency classification as 'Class I', which corresponds to a Critical severity score of 5 according to the rubric.

Plain-English summary

SCA Pharmaceuticals is recalling 386 bags of Vancomycin HCl 1 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only. The product is identified by NDC 70004-0920-59 and was distributed nationwide in the United States.

The recall is being conducted due to the presence of particulate matter. This action follows a recent recall by Hospira of vancomycin hydrochloride 10gm vials for the same reason. The affected lots are 20161228@65 (expiration 02/26/2017) and 20161214@76 (expiration 02/12/2017).

Healthcare providers and patients should stop using the affected product and contact SCA Pharmaceuticals or their local FDA office for further instructions. The FDA has classified this as a Class I recall.

The recalled product

Product
Vancomycin HCl 1 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use Only, Rx Only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0920-59
Affected units
386

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lot: 20161228@65
  • Exp 02/26/2017
  • Lot: 20161214@76
  • Exp 02/12/2017

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 7 recalled by SCA Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 7 products in this recall →

Similar recalls